Fredun Pharmaceuticals Ltd Applies for NSE Listing

Fredun Pharmaceuticals Ltd announced that its Board of Directors has approved an application to list its equity shares on the National Stock Exchange of India Limited (NSE). This decision was made during a board meeting held on November 5, 2026. The company also approved the un-audited financial results for the quarter and half-year ended September 30, 2026, along with the limited review report from its statutory auditor. The trading window for company insiders was closed from October 1, 2026, until 48 hours after the board meeting's outcome declaration.